Maravai LifeSciences Holdings, Inc.
MRVI
$3.08
-$0.21-6.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -39.62% | 35.45% | -32.21% | -15.60% | 73.31% |
| Total Depreciation and Amortization | -4.60% | 0.37% | 3.19% | 2.64% | 3.47% |
| Total Amortization of Deferred Charges | 1.00% | 2.05% | -15.18% | -29.94% | -12.73% |
| Total Other Non-Cash Items | 267.85% | -182.62% | 4,154.58% | -104.69% | -92.99% |
| Change in Net Operating Assets | -503.51% | 321.63% | -79.20% | 152.58% | -554.20% |
| Cash from Operations | -50.28% | -47.59% | -9.32% | 35.85% | -211.43% |
| Capital Expenditure | 27.75% | -1.81% | 45.10% | 10.50% | 31.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 98.06% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -20.04% | 349.46% |
| Cash from Investing | 27.75% | 9.58% | 86.01% | -369.05% | 44.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 49.36% | -0.84% | -0.26% | 99.33% | -15,022.37% |
| Issuance of Common Stock | 4,051.35% | 753.85% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 17.15% | -- | -100.00% | 117.61% | -432.58% |
| Cash from Financing | 77.99% | -437.74% | 68.69% | 97.93% | -29,295.18% |
| Foreign Exchange rate Adjustments | 275.00% | 92.79% | -252.05% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.33% | -73.86% | 59.44% | 85.40% | -5,229.52% |